Sign in to continue:

Saturday, March 7th, 2026

Gap Inc. Reports FY2025 Earnings Growth, Announces $1 Billion Share Repurchase and Provides Positive 2026 Outlook





Gap Inc. Reports Q4 and FY2025 Results, Announces Shareholder Initiatives and 2026 Outlook

Gap Inc. Delivers Strong Q4 and FY2025 Results, Authorizes \$1 Billion Share Repurchase, and Issues Positive 2026 Guidance

Key Financial Highlights

  • Q4 2025 Net Sales: \$4.2 billion, up 2% year-over-year.
  • FY2025 Net Sales: \$15.4 billion, up 2% year-over-year, at the high end of the outlook.
  • Comparable Sales: Up 3% for both Q4 and FY2025, marking the 8th consecutive quarter of positive comps.
  • Operating Income: \$1.1 billion for the year, with a 7.3% operating margin, exceeding outlook.
  • Operating Cash Flow: Generated \$1.3 billion in FY2025.
  • Free Cash Flow: \$823 million for FY2025.
  • Gross Margin: 38.1% for Q4 (down 80 bps YoY); 40.8% for FY2025 (down 80 bps YoY), impacted by tariffs.
  • Net Income: \$816 million for FY2025; diluted EPS of \$2.13.
  • Cash and Investments: \$3.0 billion at year-end, up \$414 million from prior year.

Brand Performance

  • Old Navy:
    • Q4 net sales of \$2.3 billion (+3% YoY), comps up 3%.
    • FY net sales of \$8.7 billion (+3% YoY), comps up 3%.
  • Gap:
    • Q4 net sales of \$1.1 billion (+8% YoY), comps up 7%.
    • FY net sales of \$3.5 billion (+5% YoY), comps up 6%.
  • Banana Republic:
    • Q4 net sales of \$549 million (+1% YoY), comps up 4%.
    • FY net sales of \$1.9 billion (-1% YoY), comps up 3%.
  • Athleta:
    • Q4 net sales of \$354 million (-11% YoY), comps down 10%.
    • FY net sales of \$1.2 billion (-10% YoY), comps down 9%.
    • Brand is under strategic rebuilding for the long term.

Shareholder-Focused Actions

  • New \$1 Billion Share Repurchase Authorization: Announced, replacing the prior authorization. Demonstrates confidence in future cash flows and commitment to shareholder returns.
  • Dividends:
    • Q4 dividend of \$0.165/share paid (\$62 million total).
    • Q1 FY2026 dividend approved at \$0.175/share (up ~6% vs. Q4 2025).
  • Share Repurchases: 7 million shares repurchased for \$155 million in FY2025; 372 million shares outstanding at year-end.
  • Total Cash Returned to Shareholders: \$402 million in FY2025 (dividends + repurchases).

Operational and Strategic Details

  • Store Footprint: Ended FY2025 with nearly 3,500 locations (2,474 company-operated), ~1,000 franchise stores, and about 29.6 million sq. ft. of retail space.
  • Online Sales: Represented 42% of Q4 net sales and 39% of FY2025 net sales (up 4% YoY).
  • Inventory: \$2.2 billion at year-end, up 7% YoY, primarily due to higher costs from tariffs.
  • Capital Expenditures: \$470 million in FY2025, expected to rise to ~\$650 million in FY2026.
  • Tariff Headwinds: Estimated net tariff impact reduced merchandise margin by 200 bps in Q4 and 120 bps for the year.

Fiscal 2026 Outlook (Excluding Impact of One-Time Items)

  • Net Sales: Expected to increase 2% to 3% YoY.
  • Gross Margin: Expected to be flat to up slightly from FY2025’s 40.8%.
  • Operating Margin: Adjusted operating margin of 7.3% to 7.5%.
  • Adjusted Diluted EPS: Projected at \$2.20 to \$2.35 (excluding a one-time net legal gain and charitable donation).
  • Reported EPS (Including One-Time Items): \$2.71 to \$2.86, reflecting an estimated \$313 million net gain from a legal settlement and a \$50 million charitable donation in Q1 2026.
  • Net Interest Income: \$10 million to \$15 million.
  • Effective Tax Rate: Approximately 27%.
  • Capital Expenditures: Approximately \$650 million.
  • Net Store Closures: About flat (compared to -32 in FY2025).
  • Q1 2026 Guidance:
    • Net sales up 1% to 2% YoY.
    • Gross margin down 150-200 bps YoY (with 200 bps of net tariff impact).
    • Operating expense as a % of sales about 35% (vs. 34.3% prior year).

Other Noteworthy Strategic Initiatives

  • Growth Accelerators: Continued investments in technology, AI, “Fashiontainment” platforms, and expansion into beauty and accessories.
  • Brand-Specific Plans: New store formats for Gap, reintroduction of a fragrance line, expanded accessories for holiday 2026, and repositioning Athleta for long-term growth.

Risks, Cautions, and Forward-Looking Statements

  • Gap Inc. emphasized the impact of fluctuating tariff rates, global economic volatility, consumer spending patterns, and competitive pressures as ongoing risks.
  • Uncertainties in U.S. trade policy, supply chain costs, and inventory management may also affect future results.
  • Forward-looking statements are subject to risks, including unforeseen events, regulatory changes, and the success of strategic initiatives.

Conclusion for Investors

Gap Inc. delivered a strong finish to FY2025, with solid sales growth, consistent positive comps, and robust cash flow, despite tariff-related margin pressure. The new \$1 billion share repurchase authorization and increased dividend signal management’s confidence and commitment to shareholder returns. The positive FY2026 guidance, including expected sales and profit growth, ongoing investments in digital and brand elevation, and a clear focus on operational discipline, are potentially price-sensitive and could move the share price. However, investors should monitor the continuing impact of tariffs, macroeconomic risks, and the turnaround at Athleta.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Investors should refer to Gap Inc.’s filings with the SEC and consult their financial advisor before making investment decisions.




View GAP INC Historical chart here



NightFood Holdings, Inc. (NGTF) 2026 S-1/A Filing: Financial Statements, Debt, Equity, Acquisitions, and Segment Details

NightFood Holdings, Inc. S-1/A Filing: Key Highlights and Investor Analysis Overview NightFood Holdings, Inc. (Ticker: NGTF), headquartered in Tarrytown, NY, has filed an amended S-1 registration statement, providing a detailed look into its financial...

Invesco CurrencyShares 2025 10-K Annual Report: Financials, Business Overview, Cybersecurity & Management Analysis

Invesco CurrencyShares Canadian Dollar Trust: 2025 Annual Report Key Insights Invesco CurrencyShares Canadian Dollar Trust: 2025 Annual Report – Key Points for Investors Overview Invesco CurrencyShares Canadian Dollar Trust (“the Trust”) has released its...

Apogee Therapeutics 2025 Annual Report: Pipeline Overview, Strategy, and Clinical Progress in Inflammatory and Immunology Markets

Key Highlights from Apogee Therapeutics, Inc. 2025 Annual Report: Strategic Developments and Financial Position Introduction Apogee Therapeutics, Inc. (Nasdaq: APGE) has released its Annual Report for the fiscal year ended December 31, 2025. This...

   Ad